Acuta Capital Partners’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$1.6M Buy
2021
Q4
Sell
2021
Q3
$1.7M Buy
2021
Q2
Sell
2021
Q1
$5.75M Sell
2020
Q4
$6.53M Sell
2020
Q3
$9.08M Buy
2020
Q2
$5.76M Buy